The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3
Cited by 417
Related Papers
Remote Light‐Responsive Nanocarriers for Controlled Drug Delivery: Advances and Perspectives
|Small|2019|317
Aryl hydrocarbon receptor negatively regulates NLRP3 inflammasome activity by inhibiting NLRP3 transcription
|Nature Communications|2014|204
TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation
|Nature Communications|2021|156